Gastrointestinal Malignancies

On this page

Upper GI Malignancies - Top Tract Terrors

Esophageal Carcinoma:

  • Two main types:
    • Squamous Cell Ca (SCC): Mid-upper esophagus. Risks: Smoking, alcohol, achalasia, Plummer-Vinson, hot liquids. 📌 AAH SP! (Alcohol, Achalasia, Hot liquids, Smoking, Plummer-Vinson)
    • Adenocarcinoma (ADC): Lower third. Arises from Barrett's esophagus (columnar metaplasia). Risks: GERD, obesity, smoking.
  • Clinical: Progressive dysphagia (solids then liquids), weight loss, odynophagia.

⭐ In ADC, Barrett's esophagus (intestinal metaplasia) increases cancer risk by 30-40 times.

Gastric Adenocarcinoma:

  • Lauren Classification:
    • Intestinal type: Glandular, common in high-risk areas, assoc. H. pylori, chronic gastritis, dietary nitrosamines.
    • Diffuse type: Signet ring cells, infiltrative (linitis plastica), worse prognosis, CDH1 mutation.
  • Risk Factors: H. pylori (key!), smoked/salted foods, pernicious anemia, Blood group A.
  • Signs: Virchow's node (supraclavicular LN), Sister Mary Joseph nodule (umbilical), Krukenberg tumor (ovarian mets).

Gastric signet ring cells

Colorectal Cancer - Colon Catastrophe

  • Risk: Age >50, IBD, family hx, adenomatous polyps (villous > tubular), ↓fiber/↑red meat.
  • Features:
    • Right-sided: Iron deficiency anemia, occult blood.
    • Left-sided: Altered bowel habits, rectal bleeding, obstruction. 📌 "Apple core" lesion.
  • Screening (Avg Risk, age 45): Colonoscopy (gold std) q10yrs; FIT annually.
  • Hereditary:
    • FAP (APC gene): 1000s polyps; CRC ~100% by 40; prophylactic colectomy.
    • Lynch (HNPCC): DNA mismatch repair genes (MLH1, MSH2); ↑CRC & endometrial Ca.
  • Staging: TNM. CEA for prognosis/recurrence. Treatment: Surgery ± Chemo.

⭐ Right-sided colon cancers often present with anemia, while left-sided cancers are more likely to cause changes in bowel habits or obstruction.

Hepatocellular Carcinoma - Liver Lesion Lore

  • Risk Factors: Chronic HBV/HCV, Cirrhosis (Alcohol, NAFLD), Aflatoxin B1, Hemochromatosis. 📌 Hepatitis, Cirrhosis, Contaminants (Aflatoxin).
  • Screening: Cirrhotics & high-risk HBV: Ultrasound +/- AFP every 6 months.
  • Diagnosis:
    • AFP: ↑ (>20 ng/mL abnormal; >400 ng/mL highly suggestive).
    • Imaging (LI-RADS): Arterial Phase Hyperenhancement (APHE) & Venous/Delayed Phase Washout on CT/MRI.
    • Biopsy: If imaging atypical or no underlying cirrhosis.
  • Staging: Barcelona Clinic Liver Cancer (BCLC).
  • Treatment: Resection, Transplant, Ablation (RFA), TACE, Sorafenib/Lenvatinib.

⭐ In a patient with cirrhosis, a liver lesion >1 cm showing APHE and washout on dynamic imaging (CT/MRI) is diagnostic of HCC (LI-RADS 5), often without needing biopsy.

HCC CT: Arterial phase enhancement, venous washout

Pancreatic Cancer - Pancreas Peril

CT showing pancreatic head mass with double duct sign

  • Risk Factors: Smoking (strongest), chronic pancreatitis, diabetes mellitus, obesity, family history (e.g., BRCA mutations).
  • Clinical Features:
    • Painless, progressive obstructive jaundice (esp. head of pancreas).
    • Significant weight loss, anorexia, abdominal/back pain.
    • Courvoisier's sign: Palpable, non-tender gallbladder with jaundice.
    • Trousseau's sign: Migratory thrombophlebitis.
    • New-onset diabetes mellitus in elderly.
  • Investigations:
    • Tumor marker: CA 19-9 (↑, monitor response, not for screening).
    • USG Abdomen: Initial, may show mass, dilated CBD/pancreatic duct.
    • CECT Abdomen: Preferred for diagnosis, staging, assessing resectability. "Double duct" sign.
    • EUS with FNA: For tissue diagnosis, especially for smaller tumors or when CECT is equivocal.
  • Management:
    • Surgical resection (e.g., Whipple procedure for head tumors) is the only curative option.
    • Adjuvant/Neoadjuvant chemotherapy (e.g., FOLFIRINOX).
    • Palliative care for unresectable/metastatic disease (ERCP stenting, chemotherapy, pain management).

⭐ Courvoisier's Law: A palpably enlarged, non-tender gallbladder in a jaundiced patient suggests malignant obstruction (e.g., pancreatic or periampullary cancer) rather than gallstones.

High‑Yield Points - ⚡ Biggest Takeaways

  • Esophageal SCC, common in India, linked to tobacco/betel nut; Adenocarcinoma with GERD/Barrett's.
  • Gastric cancer: H. pylori is a key risk; signet ring cells & linitis plastica mean poor prognosis.
  • Colorectal cancer (CRC): Screening colonoscopy is vital. FAP & Lynch syndrome are key hereditary causes.
  • Hepatocellular carcinoma (HCC): Hepatitis B is main cause in India; AFP is the marker.
  • Pancreatic cancer: Presents with painless jaundice (head); CA 19-9 marker. Courvoisier's sign.
  • GISTs: c-KIT (CD117) positive; treat with Imatinib.

Practice Questions: Gastrointestinal Malignancies

Test your understanding with these related questions

What is the most precancerous condition associated with an increased risk of carcinoma of the colon?

1 of 5

Flashcards: Gastrointestinal Malignancies

1/10

_____ syndrome is iron deficiency anemia with esophageal webs and atrophic glossitis and cheliosis

TAP TO REVEAL ANSWER

_____ syndrome is iron deficiency anemia with esophageal webs and atrophic glossitis and cheliosis

Plummer-Vinson

browseSpaceflip

Enjoying this lesson?

Get full access to all lessons, practice questions, and more.

Start Your Free Trial